Christopher C. Caillouet

Array ( [id] => 6249290 [patent_doc_number] => 20100137361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Tetrahydro-Quinolinylurea Derivatives' [patent_app_type] => utility [patent_app_number] => 12/700417 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15259 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137361.pdf [firstpage_image] =>[orig_patent_app_number] => 12700417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249212 [patent_doc_number] => 20100137324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'RHO-KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/698386 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16655 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137324.pdf [firstpage_image] =>[orig_patent_app_number] => 12698386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670147 [patent_doc_number] => 20110319416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions' [patent_app_type] => utility [patent_app_number] => 13/146225 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28380 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13146225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6447318 [patent_doc_number] => 20100280011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 12/694965 [patent_app_country] => US [patent_app_date] => 2010-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 25356 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280011.pdf [firstpage_image] =>[orig_patent_app_number] => 12694965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656460 [patent_doc_number] => 20110305729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Scriptaid Isosteres and Their Use in Therapy' [patent_app_type] => utility [patent_app_number] => 13/145250 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23110 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305729.pdf [firstpage_image] =>[orig_patent_app_number] => 13145250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214386 [patent_doc_number] => 08193218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Aroyl-piperidine derivatives and method of treating disorders induced by substance P' [patent_app_type] => utility [patent_app_number] => 12/690210 [patent_app_country] => US [patent_app_date] => 2010-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2748 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193218.pdf [firstpage_image] =>[orig_patent_app_number] => 12690210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099701 [patent_doc_number] => 08563579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'α-7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/688650 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12181 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12688650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321450 [patent_doc_number] => 20100113515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'PTEN INHIBITOR OR MAXI-K CHANNELS OPENER' [patent_app_type] => utility [patent_app_number] => 12/650275 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4416 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113515.pdf [firstpage_image] =>[orig_patent_app_number] => 12650275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477809 [patent_doc_number] => 20120277216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => '1,2-DIHYDRO-2-OXOQUINOLINE COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 13/393539 [patent_app_country] => US [patent_app_date] => 2009-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23464 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442505 [patent_doc_number] => 20120259121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'PROCESS FOR THE PREPARATION OF MONTELUKAST AND SALTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/515893 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3297 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6425947 [patent_doc_number] => 20100168162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'SELECTIVE INHIBITORS OF AKT AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 12/645313 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16269 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168162.pdf [firstpage_image] =>[orig_patent_app_number] => 12645313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432241 [patent_doc_number] => 20100152195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors' [patent_app_type] => utility [patent_app_number] => 12/639129 [patent_app_country] => US [patent_app_date] => 2009-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54441 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152195.pdf [firstpage_image] =>[orig_patent_app_number] => 12639129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435705 [patent_doc_number] => 08283474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors' [patent_app_type] => utility [patent_app_number] => 12/639282 [patent_app_country] => US [patent_app_date] => 2009-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54504 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12639282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487857 [patent_doc_number] => 20110251234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'MESYLATE SALT OF 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE BETA2 ADRENERGIC RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/141156 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5857 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251234.pdf [firstpage_image] =>[orig_patent_app_number] => 13141156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494400 [patent_doc_number] => 20100093743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'CARBAMIC ACID COMPOUNDS COMPRISING A BICYCLIC HETEROARYL GROUP AS HDAC INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/636949 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39829 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093743.pdf [firstpage_image] =>[orig_patent_app_number] => 12636949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231638 [patent_doc_number] => 20100184739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Modulators of ATP-Binding Cassette Transporters' [patent_app_type] => utility [patent_app_number] => 12/635927 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118789 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184739.pdf [firstpage_image] =>[orig_patent_app_number] => 12635927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638369 [patent_doc_number] => 20130030172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'Methods of Preparing Quinoline Derivatives' [patent_app_type] => utility [patent_app_number] => 13/132650 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9746 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527976 [patent_doc_number] => 08304546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Quinolone compound and pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 12/668164 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58889 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12668164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772640 [patent_doc_number] => 08426597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases' [patent_app_type] => utility [patent_app_number] => 13/131722 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5425 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13131722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951449 [patent_doc_number] => 20130197230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'METHODS OF PREPARING QUINOLINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/129183 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10134 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129183 [rel_patent_id] =>[rel_patent_doc_number] =>)